Sensei Biotherapeutics Inc (SNSE)
0.51
-0.01
(-1.35%)
USD |
NASDAQ |
Jan 08, 12:58
Sensei Biotherapeutics Research and Development Expense (Annual): 18.30M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Relmada Therapeutics Inc | 54.81M |
Genprex Inc | 17.62M |
Ensysce Biosciences Inc | 7.588M |
IN8bio Inc | 16.83M |
NovaBay Pharmaceuticals Inc | 0.068M |